Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical data trend for Adeshwar Meditex's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543309 vs ISRG, BDX, MDLN: Buyback Yield % Comparison
For the Medical Instruments & Supplies subindustry, Adeshwar Meditex's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adeshwar Meditex Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adeshwar Meditex's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Adeshwar Meditex's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adeshwar Meditex (BOM:543309) has a Buyback Yield % of 0.00 as of Aug. 16, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Adeshwar Meditex and its competitors. According to the industry distribution chart, Adeshwar Meditex ranks #999999 out of 341 companies in the Medical Devices & Instruments industry.
Is Adeshwar Meditex's Buyback Yield % too high?
Adeshwar Meditex's current Buyback Yield % is 0.00. Based on the distribution chart, Adeshwar Meditex ranks #999999 out of 341 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Adeshwar Meditex has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Adeshwar Meditex's Buyback Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adeshwar Meditex ranks #999999 out of 341 companies for Buyback Yield %. This places Adeshwar Meditex in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Adeshwar Meditex and its competitors. Adeshwar Meditex's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adeshwar Meditex stock overvalued right now?
Based on GuruFocus' analysis, Adeshwar Meditex (BOM:543309) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹15.03, compared to a current price of ₹16.80 — trading 11.8% above its estimated fair value. The current Buyback Yield % is 0.00. Adeshwar Meditex's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Adeshwar Meditex (BOM:543309), the current Buyback Yield % is 0.00 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adeshwar Meditex (BOM:543309) Overvalued in 2026?
Based on GuruFocus' analysis, Adeshwar Meditex stock appears to be overvalued.
The current stock price of ₹16.80 is trading 11.8% above its estimated GF Value™ of ₹15.03.
GuruFocus considers Adeshwar Meditex to be Modestly Overvalued.
Key valuation signals for BOM:543309:
Buyback Yield %: 0.00
GF Value™: ₹15.03 vs. price of ₹16.80 (11.8% above fair value)
No single metric tells the full story. See the BOM:543309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adeshwar Meditex Ltd is engaged in manufacturing surgical dressings and external preparations products such as Sterile surgical wound dressing, Combine dressing, Gauze Dressing and Cotton Products, Medical Bandages and Plaster, Antiseptics / Disinfectants, and others.
64GF Score
Get the complete analysis for BOM:543309
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543309 has been successfully added to your 
